Literature DB >> 18238934

Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.

Kerry Montefour1, Jeanne Frieden, Sue Hurst, Cindy Helmich, Denielle Headley, Mary Martin, Deborah A Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18238934

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN： 0279-5442            Impact factor:   1.708


× No keyword cloud information.
  34 in total

1.  In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Authors:  C Silvestri; O Cirioni; D Arzeni; R Ghiselli; O Simonetti; F Orlando; G Ganzetti; S Staffolani; L Brescini; M Provinciali; A Offidani; M Guerrieri; A Giacometti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-11       Impact factor: 3.267

2.  Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site.

Authors:  Lakshmanane Premkumar; Fabian Kurth; Wilko Duprez; Morten K Grøftehauge; Gordon J King; Maria A Halili; Begoña Heras; Jennifer L Martin
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

3.  Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.

Authors:  Lona Mody; Kristen E Gibson; Amanda Horcher; Katherine Prenovost; Sara E McNamara; Betsy Foxman; Keith S Kaye; Suzanne Bradley
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-15       Impact factor: 3.254

4.  Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia.

Authors:  Duchao Zhang; Jingjing Xia; Yaping Xu; Meiliang Gong; Yu Zhou; Lixin Xie; Xiangqun Fang
Journal:  Clin Exp Med       Date:  2014-12-28       Impact factor: 3.984

5.  Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations.

Authors:  Mona M Abdelkader; Khaled M Aboshanab; Marwa A El-Ashry; Mohammad M Aboulwafa
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

6.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

7.  Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens.

Authors:  Ni Tien; Bang-Jau You; Hui-Lan Chang; Hsiu-Shen Lin; Chin-Yi Lee; Tung-Ching Chung; Jang-Jih Lu; Chao-Chin Chang
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

8.  Characterization of Polymyxin B Biodistribution and Disposition in an Animal Model.

Authors:  Pooja Manchandani; Jian Zhou; Kimberly R Ledesma; Luan D Truong; Diana S-L Chow; Jason L Eriksen; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

9.  Outcomes of critically ill cancer patients with Acinetobacter baumannii infection.

Authors:  Silvio A Ñamendys-Silva; Paulina Correa-García; Francisco J García-Guillén; María O González-Herrera; Américo Pérez-Alonso; Julia Texcocano-Becerra; Angel Herrera-Gómez; Patricia Cornejo-Juárez; Abelardo Meneses-García
Journal:  World J Crit Care Med       Date:  2015-08-04

10.  Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.

Authors:  Jade Bojkovic; Daryl L Richie; David A Six; Christopher M Rath; William S Sawyer; Qijun Hu; Charles R Dean
Journal:  J Bacteriol       Date:  2015-12-14       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.